C07F 9/2454
The amide moiety containing a substituent or a structure which is considered
Official title: {the amide moiety containing a substituent or a structure which is considered as characteristic}
C07F9/2454 (The amide moiety containing a substituent or a structure which is considered) appears on 423 US grants and 228 published applications in this corpus.
Search patents in C07F- Granted patents
- 423
- Published applications
- 228
- Assignees
- 232
- Inventors
- 976
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 15 | 0 |
| 1978 | 17 | 0 |
| 1979 | 17 | 0 |
| 1980 | 19 | 0 |
| 1981 | 17 | 0 |
| 1982 | 7 | 0 |
| 1983 | 12 | 0 |
| 1984 | 10 | 0 |
| 1985 | 10 | 0 |
| 1986 | 9 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 8 | 0 |
| 1990 | 6 | 0 |
| 1991 | 3 | 0 |
| 1992 | 7 | 0 |
| 1993 | 10 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 11 | 0 |
| 1997 | 8 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 8 | 0 |
| 2002 | 6 | 5 |
| 2003 | 5 | 5 |
| 2004 | 4 | 12 |
| 2005 | 7 | 10 |
| 2006 | 7 | 11 |
| 2007 | 6 | 10 |
| 2008 | 5 | 7 |
| 2009 | 6 | 4 |
| 2010 | 5 | 13 |
| 2011 | 2 | 7 |
| 2012 | 10 | 4 |
| 2013 | 5 | 6 |
| 2014 | 11 | 13 |
| 2015 | 7 | 12 |
| 2016 | 12 | 14 |
| 2017 | 6 | 10 |
| 2018 | 9 | 13 |
| 2019 | 11 | 15 |
| 2020 | 14 | 9 |
| 2021 | 9 | 6 |
| 2022 | 6 | 4 |
| 2023 | 7 | 14 |
| 2024 | 3 | 8 |
| 2025 | 3 | 11 |
| 2026 | 5 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Solid supports and phosphoramidite building blocks for oligonucleotide conjugates15 Sep 2026US 12,735,387 B2AM Chemicals LLC
- Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereof16 Jun 2026US 12,655,140 B2Shanghai Yingli Pharmaceutical Co., Ltd
- Probe related reagents and methods2 Jun 2026US 12,643,916 B2Brentano Biotechnology Associates
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Continuous flow process for preparation of acephate and its intermediates27 Jan 2026US 12,534,481 B2Upl Ltd
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Akr1c3-activated dna alkylating agent, and medical application thereof11 Jun 2026US 2026/0159536 A1Ascentawits Pharmaceuticals, Ltd.
- Method for producing imidic acid or imidic acid salt7 May 2026US 2026/0125405 A1Central Glass Company, Limited
- Phosphatidylamine compounds including a plurality of tertiary amino group structures and compositions thereof26 Mar 2026US 2026/0085081 A1Peking University
- Processes for producing nitriles and phosphorus-containing catalysts for use in such processes5 Feb 2026US 2026/0034540 A1INV Nylon Chemicals Americas, LLC
Most cited
By later US patents
- Methods for the preparation of diasteromerically pure phosphoramidate prodrugs97US 9,090,642 B2Gilead Sciences, Inc. · 2015
- Oligonucleotide functionalizing reagents92US 4,914,210 ACetus Corporation · 1990
- 7-substituted tetracycline compounds84US 6,818,635 B2Paratek Pharmaceuticals, Inc. · 2004
- Nucleoside phosphoramidates78US 8,618,076 B2Gilead Pharmasset LLC · 2013
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003